We are one of Australia’s flagship biomedical research institutes

Established in 2000, through investment from Griffith University and the Queensland State Government, we strive to be world leaders in developing next generation drugs, vaccines and diagnostics for diseases of global impact.

Our advantage is our focused approach towards drug, vaccine and diagnostic technology discovery and development using world-leading scientific expertise and dedication to discovering preventions and cures for a number of human diseases including infectious diseases and cancers.

The Institute boasts some of the world’s most renowned research leaders and state-of-the-art facilities. This rich research environment provides exceptional postgraduate education programs for the nation’s future scientists.

Our leadership team

Director

Professor Mark von Itzstein

Mark has international standing in glycoscience, medicinal chemistry and drug discovery, particularly in the area of anti-infective drug discovery.

He has established an internationally-recognised research program that is investigating the discovery of novel anti-microbial drugs, including novel anti-influenza drugs, anti-parainfluenza and anti-cancer drugs based on carbohydrate-related pathways and the outcomes of these programs are apparent from his publication record.

The story behind Mark Griffith Experts profile

Deputy Director

Professor Michael Jennings

Michael has international standing in infectious diseases research with a focus on glycoscience, genetics, epigenetics and vaccine development, particularly in pathogenic Neisseria and Haemophilus influenzae.

His current research is investigating the molecular basis for interactions between a range of pathogens and the human host and the application of this data to develop strategies for diagnostics, prevention and treatment of disease.

General Manager

Dr Chris Davis

Having more than thirteen years management experience in innovation and commercialisation, working at the academic/industry interface, Chris' role is to lead a group of professionals dedicated to the strategic and operational development of the institute. As general manager, his prime focus is on translation and commercialisation of our scientific discoveries for social and economic benefit, locally and globally.

Chris has held a number of board positions. He is currently Deputy Chair of the Ausbiotech Ltd Qld Committee.

Our researchers

Meet the experts who make up our Institute and find out more about our individual research strengths.

Glycomics org chart

Gold Coast Health and Knowledge Precinct

Asia—Pacific’s emerging health and innovation hub, the 200-hectare Gold Coast Health and Knowledge Precinct, is a unique global business location for industry development, research collaboration and jobs of the future.

Supported by $5 billion in infrastructure, including the world-class Griffith University and two major hospitals, the Precinct is transforming Australia’s leading lifestyle city. With a combination of expertise, infrastructure, land and lifestyle unique in Australia, nine hectares of greenfield land are available for health and innovation investment, serviced by the Gold Coast light rail and with easy transport access.

The Institute for Glycomics is the flagship Life Sciences institute within the GCHKP, which has a strong global investment attraction strategy for leading biotechnology companies, leveraging clinical research and trial opportunities with the co-located Gold Coast University Hospital and Gold Coast Private Hospital, as well as Menzies Health Institute Queensland.The GCHKP, which currently boasts almost 10,000 staff and more than 18,000 students, is set to employ over 26,000 people—11% of current Gold Coast jobs—generating gross value of $2.9 billion for the city’s economy.

The GCHKP hosts the Gold Coast 2018 Commonwealth Games Athletes Village, to evolve into a vibrant $550 million mixed-use community to live, work and learn, surrounded by seven hectares of parklands.

The Precinct is being developed in a unique partnership between all three levels of government and private investment, with a project office funded by City of Gold Coast, Griffith University and Gold Coast Health facilitating infrastructure development and investment attraction.The GCHKP represents a smart investment in Australia’s fastest growing major city, with a stable, diversifying economy, competitive taxes, skilled workforce and a climate and lifestyle second to none.Investment incentives are available.

Screen Shot 2017-07-05 at 9.19.26 AM.png

Want to know more?

Get in touch with the Institute for Glycomics